Hoang-Lan Nguyen

Hoang-Lan Nguyen, PhD, currently serves as the Executive Director of Medical Writing at TORL Biotherapeutics, LLC, starting in September 2024. Prior to this role, Nguyen held significant positions at BeiGene as Director of Medical Writing and Quality Control, Hutchison MediPharma as Director of Medical Writing, and Regeneron Pharmaceuticals, Inc. as Principal Medical Writer. Previous experience includes serving as a Senior Medical Writer at Mesoblast Limited and Consultant Medical Writer at Nascent Medical, LLC. Additionally, Nguyen was a Research Assistant Professor at Stony Brook University, overseeing research projects, supervising staff, and teaching undergraduate courses. Nguyen's career began as a Senior Scientist at Cornerstone Pharmaceuticals, contributing to IND filings and securing funding through grants. Academic qualifications include a PhD in Cell/Cellular and Molecular Biology from Columbia University and a BA from the University of Pennsylvania with double majors in History and Biology.